Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Metlife ( (MET) ) is now available.
On September 2, 2025, MetLife announced its decision to redeem all outstanding shares of its 3.850% fixed rate reset non-cumulative preferred stock, Series G, with a liquidation preference of $1,000 per share. The redemption will occur on September 15, 2025, and will not include accrued dividends, which will be paid separately. This strategic move may impact MetLife’s financial operations and stakeholder interests by altering its capital structure.
The most recent analyst rating on (MET) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.
Spark’s Take on MET Stock
According to Spark, TipRanks’ AI Analyst, MET is a Outperform.
MetLife’s overall stock score reflects strong financial performance and strategic initiatives that support growth. The earnings call provided positive insights into operational efficiency and capital returns, while recent corporate events bolster long-term prospects. Technical indicators suggest caution due to potential resistance levels, but the valuation remains attractive with a solid dividend yield.
To see Spark’s full report on MET stock, click here.
More about Metlife
MetLife, Inc. (NYSE: MET) is a leading global financial services company, providing insurance, annuities, employee benefits, and asset management services. Founded in 1868, MetLife operates in over 40 markets worldwide, holding significant positions in the United States, Asia, Latin America, Europe, and the Middle East.
Average Trading Volume: 2,997,110
Technical Sentiment Signal: Strong Buy
Current Market Cap: $54.11B
For an in-depth examination of MET stock, go to TipRanks’ Overview page.